Aptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Aptamer-PEG-modified Fe3O4@Mn as a novel T1- and T2- dual-model MRI contrast agent targeting hypoxia-induced cancer stem cells

Published:2016-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zhu Haitao,Zhang Lirong,Liu Yanfang,Zhou Yuepeng,Wang Kang,Xie Xiaodong,Song Lian,Wang Dongqing,Han Chunlei,Chen Qiuyun

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep39245.pdf

Reference42 articles.

1. Wilson, W. R. & Hay, M. P. Targeting hypoxia in cancer therapy. Nature reviews. Cancer 11, 393–410, doi: 10.1038/nrc3064 (2011).

2. Paolicchi, E. et al. Targeting hypoxic response for cancer therapy. Oncotarget 7, 13464–13478, doi: 10.18632/oncotarget.7229 (2016).

3. Semenza, G. L. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends in pharmacological sciences 33, 207–214, doi: 10.1016/j.tips.2012.01.005 (2012).

4. Lee, K. et al. Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization. Proceedings of the National Academy of Sciences of the United States of America 106, 17910–17915, doi: 10.1073/pnas.0909353106 (2009).

5. Munoz-Pinedo, C., El Mjiyad, N. & Ricci, J. E. Cancer metabolism: current perspectives and future directions. Cell death & disease 3, e248, doi: 10.1038/cddis.2011.123 (2012).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lanthanide vanadate-based nanoparticles as multimodal T1 -T2 MRI contrast agent and NIR luminescent imaging probe;Journal of Alloys and Compounds;2024-10

2. Aptamers: ushering in new hopes in targeted glioblastoma therapy;Journal of Drug Targeting;2024-07-03

3. A review of design criteria for cancer-targeted, nanoparticle-based MRI contrast agents;Applied Materials Today;2024-04

4. Aptamer-mediated nano-therapy for pancreatic cancer;Recent Advances in Nanocarriers for Pancreatic Cancer Therapy;2024

5. Iron-Based Ionic Liquids for Magnetic Resonance Imaging Application;Industrial Applications of Ionic Liquids;2023-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3